Skip to main content

Animations

MJFF Publications

8231 - 8240 of 8666 Results
Title
Year
  • Year
  • 2018
  • 2016
  • 2021
  • 2020
  • 2013
  • 2017
  • 2021
  • 2022
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-34490-9
    Citation Count: 143
  • Summary Details
    RESTRICTED
    Title: Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26614
    Best OA location URL:
    Citation Count: 118
  • Summary Details
    OPEN
    Title: Triggers and alleviating factors for fatigue in Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0245285
    Citation Count: 24
  • Summary Details
    OPEN
    Title: The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-202249
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones
    Journal Name: European Journal of Medicinal Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.ejmech.2013.10.052
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Normative morphometric data for cerebral cortical areas over the lifetime of the adult human brain
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.019
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Environmental Risk Factors for Progressive Supranuclear Palsy
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20173
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and Neuroprotection
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsami.9b10426
    Best OA location URL:
    Citation Count: 50
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.